Childhood cancer survivors face heightened risks of chronic kidney disease and hypertension, necessitating urgent updates to ...

Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer's Jivi antihemophilic factor ...

International Conference used FDA-approved tools to see how sleep can impact other parts of recovery for patients in the ...

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill, shares promising results of ensifentrine in helping patients with insufficient chronic obstructive ...

Panelists discuss how early diagnosis of immunoglobulin A (IgA) nephropathy enables timely interventions that can ...

Panelists discuss how disease-modifying therapies for immunoglobulin A (IgA) nephropathy, though initially more expensive ...

Solutions depend on listening to individuals with lived experience, rebuilding trust, and recognizing the humanity of every ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Panelists discuss how currently available ALK inhibitors compare in terms of efficacy, durability of response, and central ...

Margrit Wiesendanger, MD, PhD, explores lupus symptoms, diagnosis challenges, and the importance of early detection to prevent inflammation-related damage.